{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:25:04Z","timestamp":1767651904550},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T00:00:00Z","timestamp":1290643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11102-010-0276-x","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T07:32:54Z","timestamp":1290583974000},"page":"168-173","source":"Crossref","is-referenced-by-count":16,"title":["Analysis of thrombophilic genetic mutations in patients with Sheehan`s syndrome: is thrombophilia responsible for the pathogenesis of Sheehan`s syndrome?"],"prefix":"10.1007","volume":"14","author":[{"given":"Deniz","family":"Gokalp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpaslan","family":"Tuzcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mithat","family":"Bahceci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Ayyildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Yurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulistan","family":"Alpagat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,25]]},"reference":[{"issue":"4","key":"276_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0025-6196(12)60946-X","volume":"65","author":"B Sheithauer","year":"1990","unstructured":"Sheithauer B, Sano T, Kovacs K, Young W Jr, Ryan N, Randall R (1990) The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 patients. Mayo Clin Proc 65(4):461","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"276_CR2","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1210\/jc.2001-020242","volume":"87","author":"R Goswami","year":"2002","unstructured":"Goswami R, Kochupillai N, Crock P, Jaleel A, Gupta N (2002) Pituitary autoimmunity in patients with Sheehans syndrome. J Clin Endocr Metab 87(9):4137","journal-title":"J Clin Endocr Metab"},{"key":"276_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1023\/B:PITU.0000023425.20854.8e","volume":"6","author":"F Kelestimur","year":"2003","unstructured":"Kelestimur F (2003) Sheehan\u2019s syndrome. Pituitary 6:181\u2013188","journal-title":"Pituitary"},{"key":"276_CR4","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/humrep\/17.6.1633","volume":"17","author":"H Carp","year":"2002","unstructured":"Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A (2002) Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 17:1633\u20131637","journal-title":"Hum Reprod"},{"key":"276_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/107602960501100101","volume":"11","author":"RL Bick","year":"2005","unstructured":"Bick RL, Hoppensteadt D (2005) Recurrent miscarriage syndrome and infertility due to blood coagulation protein\/platelet defects: a review and update. Clin App Thromb Hemost 11:1\u201313","journal-title":"Clin App Thromb Hemost"},{"key":"276_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/humrep\/15.2.458","volume":"15","author":"ZJ Foka","year":"2000","unstructured":"Foka ZJ, Lambropoulos AF, Saravelos H et al (2000) Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 15:458\u2013462","journal-title":"Hum Reprod"},{"key":"276_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1056\/NEJM199603213341203","volume":"334","author":"M Heijer den","year":"1996","unstructured":"den Heijer M, Koster T, Blom HJ et al (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759\u2013762","journal-title":"N Engl J Med"},{"key":"276_CR8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/1529-0131(200010)43:10<2349::AID-ANR24>3.0.CO;2-J","volume":"43","author":"D Tassies","year":"2000","unstructured":"Tassies D, Espinosa G, Munoz-Rodriguez FJ et al (2000) The 4G\/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis Rheum 43:2349\u20132358","journal-title":"Arthritis Rheum"},{"key":"276_CR9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1055\/s-0037-1615105","volume":"79","author":"M Stegnar","year":"1998","unstructured":"Stegnar M, Uhrin P, Peternel P et al (1998) The 4G\/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost 79:975\u2013979","journal-title":"Thromb Haemost"},{"key":"276_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/path.1700450118","volume":"45","author":"HL Sheehan","year":"1937","unstructured":"Sheehan HL (1937) Postpartum necrosis of the anterior pituitary. J Path Bacteriol 45:189\u2013214","journal-title":"J Path Bacteriol"},{"issue":"1","key":"276_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/edrv-1-1-100","volume":"1","author":"JD Veldhuis","year":"1980","unstructured":"Veldhuis JD, Hammond JM (1980) Endocrine function after spontaneous infarction of the human pituitary: report, review, and reappraisal. Endocr Rev 1(1):100\u2013107","journal-title":"Endocr Rev"},{"key":"276_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/0002-9378(78)90765-2","volume":"132","author":"D Di Ziegra","year":"1978","unstructured":"Di Ziegra D, Kletzky DA, Mishell DR (1978) Diagnosis of Sheehan\u2019s syndrome using sequental pituitary stimulation tests. Am J Obstet Gynecol 132:348\u2013353","journal-title":"Am J Obstet Gynecol"},{"key":"276_CR13","first-page":"261","volume":"244","author":"DM Roberts","year":"1998","unstructured":"Roberts DM (1998) Sheehan\u2019s syndrome. Am Fam Physician 244:261\u2013266","journal-title":"Am Fam Physician"},{"key":"276_CR14","first-page":"386","volume":"49","author":"D Gupta","year":"2001","unstructured":"Gupta D, Gaiha M, Mahajan R, Daga MK (2001) Atypical presentation of sheehan\u2019s syndrome without postpartum hemorrhage. J Assoc Physicians India 49:386\u2013387","journal-title":"J Assoc Physicians India"},{"key":"276_CR15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0140-6736(03)12490-7","volume":"361","author":"K Kovacs","year":"2003","unstructured":"Kovacs K (2003) Sheehan syndrome. Lancet 361:520\u2013522","journal-title":"Lancet"},{"issue":"2","key":"276_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/000331970605700209","volume":"57","author":"S Kalkanli","year":"2006","unstructured":"Kalkanli S, Ayyildiz O, Tiftik N, Batun S, Isikdogan A et al (2006) Factor V Leiden mutation in venous thrombosis in southeast Turkey. Angiology 57(2):193\u2013196","journal-title":"Angiology"},{"key":"276_CR17","first-page":"313","volume":"39","author":"A Gurgey","year":"1997","unstructured":"Gurgey A, Mesci L (1997) The prevalence of factor V Leiden (1691G\u00a0\u2192\u00a0A) mutation in Turkey. Turk J Pediatr 39:313\u2013315","journal-title":"Turk J Pediatr"},{"key":"276_CR18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","volume":"79","author":"FR Rosendaal","year":"1998","unstructured":"Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M et al (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79:706\u2013708","journal-title":"Thromb Haemost"},{"key":"276_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00380-003-0760-6","volume":"19","author":"O Ayyildiz","year":"2004","unstructured":"Ayyildiz O, Kalkanli S, Batun S, Aybak M, Isikdogan A, Tiftik N, Bolaman Z, Soker M, Muftuoglu E (2004) Prothrombin G20210A gene mutation with Lightcycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey. Heart Vessels 19:164\u2013166","journal-title":"Heart Vessels"},{"key":"276_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(SICI)1096-8652(199807)58:3<249::AID-AJH20>3.0.CO;2-3","volume":"58","author":"N Akar","year":"1998","unstructured":"Akar N, Misirlioglu M, Akar E, Avci F, Yalcin A (1998) Prothrombin gene 20210 G-A mutations in Turkish population. Am J Hematol 58:249","journal-title":"Am J Hematol"},{"issue":"3","key":"276_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/01.moh.0000130315.41033.32","volume":"11","author":"E Castoldi","year":"2004","unstructured":"Castoldi E, Rosing J (2004) Factor V Leiden: a disorder of factor V anticoagulant function. Curr Opin Hematol 11(3):176\u2013181","journal-title":"Curr Opin Hematol"},{"key":"276_CR22","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","volume":"346","author":"KW Bloemenkamp","year":"1995","unstructured":"Bloemenkamp KW, Rosendaal FR, Helmerhorst FM et al (1995) Enhancement by factor V Leiden mutation of risk of deep vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 346:1593\u20131596","journal-title":"Lancet"},{"key":"276_CR23","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood.V86.12.4700.bloodjournal86124700","volume":"86","author":"FR Rosendaal","year":"1995","unstructured":"Rosendaal FR, Koster T, Vandenbroucke JP et al (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 86:4700\u20134702","journal-title":"Blood"},{"key":"276_CR24","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","volume":"88","author":"SR Poort","year":"1996","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698\u20133703","journal-title":"Blood"},{"key":"276_CR25","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"D Wald","year":"2002","unstructured":"Wald D, Law M, Morris J (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Brit Med J 325:1202\u20131208","journal-title":"Brit Med J"},{"key":"276_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(02)07876-5","volume":"359","author":"I Quere","year":"2002","unstructured":"Quere I, Perneger T, Zittoun J, Bellet H, Gris JC, Daures JP et al (2002) Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet 359:747\u2013752","journal-title":"Lancet"},{"issue":"2","key":"276_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0049-3848(02)00096-8","volume":"106","author":"P Hainaut","year":"2002","unstructured":"Hainaut P, Jaumotte J, Verhelst D, Wallemacq P, Gala JP, Lavenne E et al (2002) Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases. Thromb Res 106(2):121\u2013125","journal-title":"Thromb Res"},{"issue":"4","key":"276_CR28","first-page":"566","volume":"80","author":"S Eichinger","year":"1998","unstructured":"Eichinger S, Stumpflen A, Hirschi M, Bialonczyk C, Herkner K, Stain M et al (1998) Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost 80(4):566\u2013569","journal-title":"Thromb Haemost"},{"key":"276_CR29","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1086\/301825","volume":"62","author":"NM Put van der","year":"1998","unstructured":"van der Put NM, Gabreels F, Stevens EM et al (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural ltube defects? Am J Hum Genet 62:1044\u20131051","journal-title":"Am J Hum Genet"},{"key":"276_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/mgme.1998.2714","volume":"64","author":"I Weisberg","year":"1998","unstructured":"Weisberg I, Tran P, Christensen B et al (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169\u2013172","journal-title":"Mol Genet Metab"},{"key":"276_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","volume":"3","author":"M Heijer den","year":"2005","unstructured":"den Heijer M, Lewington S, Clarke R (2005) Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. Thromb Haemost 3:292\u2013299","journal-title":"Thromb Haemost"},{"issue":"7","key":"276_CR32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1373\/49.7.1081","volume":"49","author":"A Dossenbach-Glaninger","year":"2003","unstructured":"Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M et al (2003) Plasminogen activator inhibitor 1 4G\/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 49(7):1081\u20131086","journal-title":"Clin Chem"},{"issue":"1","key":"276_CR33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1046\/j.1365-2141.2000.02321.x","volume":"111","author":"R Segui","year":"2000","unstructured":"Segui R, Estelles A, Mira Y et al (2000) PAI-1 promoter 4G\/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol 111(1):122\u2013128","journal-title":"Br J Haematol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-010-0276-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-010-0276-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-010-0276-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-010-0276-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T01:51:02Z","timestamp":1592099462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-010-0276-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,25]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["276"],"URL":"https:\/\/doi.org\/10.1007\/s11102-010-0276-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,25]]}}}